Evidence map›Paper›PMID 40046189›Full record

ArticleFrontiers in cellular and infection microbiology2025

Molecular epidemiology of

Ilya Kandinov, Boris Shaskolskiy, Dmitry Kravtsov, Anatoliy Larkin, Alexei Kubanov, Marina Shpilevaya, Julia Shagabieva, Nikita Nosov, Dmitry Gryadunov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ilya KandinovCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Boris ShaskolskiyCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Dmitry KravtsovCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Anatoliy LarkinCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Alexei KubanovState Research Center of Dermatovenerology and Cosmetology, Russian Ministry of Health, Moscow, Russia.
Marina ShpilevayaState Research Center of Dermatovenerology and Cosmetology, Russian Ministry of Health, Moscow, Russia.
Julia ShagabievaState Research Center of Dermatovenerology and Cosmetology, Russian Ministry of Health, Moscow, Russia.
Nikita NosovState Research Center of Dermatovenerology and Cosmetology, Russian Ministry of Health, Moscow, Russia.
Dmitry GryadunovCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The emergence of multidrug resistance in Methods: A total of 996 N Results: No ceftriaxone-resistant isolates were found in Russia, however, the number of isolates with reduced susceptibility to ceftriaxone has increased to 22.6% in recent years. Since 2020, approximately 12.5% of isolates have exhibited resistance to azithromycin annually. Two clusters of isolates pose a particular threat to Russia: NG-MAST G2212, linked to MLST 1901/1902, carries a mosaic structure in the Conclusions: The native genetic strains of

Indexed as

GonorrheaNeisseria gonorrhoeaeAdultAnti-Bacterial AgentsAzithromycinCeftriaxoneDrug Resistance, Multiple, BacterialFemaleForecastingGenotypeHumansMaleMicrobial Sensitivity TestsMolecular EpidemiologyMultilocus Sequence TypingRussiaAnti-Bacterial AgentsAzithromycinCeftriaxoneantibiotic resistancegenetic determinants of drug resistancegenotypingmolecular epidemiologyNeisseria gonorrhoeae

Identifiers

PMID40046189
PMCPMC11879935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.